Industrial preparations of Named Patient Products (NPPs) in allergology
7 October 2022S. Slimani (Antony - France)
Stallergenes Greer is a fully integrated global biopharmaceutical company specialising in the diagnosis and treatment of allergies through the development and commercialization of allergen immunotherapy (AIT) products and services.
The large range of allergen extracts are derived from natural sources (pollens, grasses, house dust mites, venoms, molds, danders.) using state-of-the-art technologies to provide patients with high quality allergen immunotherapy treatments adapted to their needs and profile.
Prior to the extraction of the allergens, we select and harvest the raw material which guarantees both the quality and the reproducibility of the allergenic extracts
Products can be manufactured in standardised form and can also be tailored to the specific needs of patients in terms of composition, concentration, and dosage. These personalised solutions, known as Named Patient Products (NPPs), are prepared according to the allergist’s prescription and the patient profile.
Stallergenes Greer implements a quality management system to ensure control of manufacturing and distribution processes.
In accordance with the most demanding standards of the pharmaceutical industry, to ensure batch-to-batch consistency, quality, and purity of its products, Stallergenes Greer has established stringent controls of the source and nature of the source materials and applies hundreds of process controls to ensure that target quality attributes are delivered. Each batch of product is the combination of the product, documentation, and controls.
Allergen immunotherapy innovation has evolved significantly over the years. Stallergenes Greer continues to capitalize on its century of experience in allergen immunotherapy to produce personalized treatments. Our approach to manufacturing the highest quality products relies on continuous learning and improvements to ensure we are continually modernizing our quality controls and improving our processes through investments in our facilities